Umb Financial Corp
$3.62B- Market cap
- $10.92B
- Debt
- +$474.23M
- Cash
- −$7.77B
Capital structure 96% equity / 4% debt · EV / Revenue 1.08x · EV / EBITDA 1.49x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: UMBF stock price at premium vs FLGT $143.76 current versus $74.30 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at FLGT's multiple
Implied fair value · at UMBF's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: UMBF FY 2025 (ended Dec 31, 2025) · FLGT FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 96% equity / 4% debt · EV / Revenue 1.08x · EV / EBITDA 1.49x
Capital structure 100% equity / 0% debt · EV / Revenue 1.53x
UMBF carries the larger enterprise value at $3.62B against $493.16M; UMBF trades on the lower EV / Revenue multiple (1.08x vs 1.53x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
UMB FINANCIAL CORP · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
FULGENT GENETICS, INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.06x
0.00x
Net debt / EBITDA
Leverage against operating earnings
-3.00x
1.15x
Cash and equivalents
Liquid reserves on the balance sheet
$7.77B
$50.19M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
FIFTH THIRD BANCORP
UMBF vs FITB
REGIONS FINANCIAL CORP
UMBF vs RF
KEYCORP /NEW/
UMBF vs KEY
HANCOCK WHITNEY CORP
UMBF vs HWC
OLD NATIONAL BANCORP /IN/
UMBF vs ONB
NEOGENOMICS INC
UMBF vs NEO
Natera, Inc.
UMBF vs NTRA
Guardant Health, Inc.
UMBF vs GH
EXACT SCIENCES CORP
UMBF vs EXAS
OPKO HEALTH, INC.
UMBF vs OPK
$474.23M
$476.00K
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.